CYTKCYTOKINETICS INC
CUSIP 23282W605 · common stock
5 tracked investors held CYTOKINETICS INC (CYTK) at the end of Q3 2026, worth $105.4M in total. The largest holder was Ken Fisher, with 0.0% of its portfolio. Joel Greenblatt sold out of its position this quarter.
Holders · Q3 2026
5
New holders
0
Value held
$105.4M
Quarter-end price (est.)
$65.91
Investors holding CYTK · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| Ken Fisher Fisher Asset Management, LLC | 0.02% | 818,832 | $54M | ADD+10.1% |
| Adar1 Capital Management ADAR1 Capital Management, LLC | 1.29% | 461,407 | $30.4M | ADD+0.8% |
| Julian Baker Baker Bros. Advisors LP | 0.07% | 211,267 | $13.9M | HOLD |
| Chuck Royce Royce & Associates LP | 0.06% | 102,285 | $6.7M | ADD+0.7% |
| Ron Baron BAMCO Inc. (Baron Capital) | 0.00% | 6,000 | $395.5K | REDUCE-40.0% |
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| Joel Greenblatt | 0.00% | 5,367 | $457.2K | EXIT |